<PAGE>

                             UNITED STATES
                  SECURITIES AND EXCHANGE COMMISSION
                         Washington, D.C.  20549

                              FORM 10-K

[X]  ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
                        EXCHANGE ACT OF 1934

                 For The Year Ended December 31, 2005

                                 OR

[ ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                   SECURITIES EXCHANGE ACT OF 1934

              For the transition period from N/A to N/A
                                             ---    ---

                      Commission File No. 814-55

TECHNOLOGY FUNDING VENTURE PARTNERS IV, AN AGGRESSIVE GROWTH FUND, L.P.
-----------------------------------------------------------------------
         (Exact name of Registrant as specified in its charter)

          DELAWARE                            94-3054600
-------------------------------    ----------------------------------
(State or other jurisdiction of   (I.R.S. Employer Identification No.)
incorporation or organization)

1107 Investment Boulevard, Suite 180
El Dorado Hills, California                                   95762
---------------------------------------                     --------
(Address of principal executive offices)                   (Zip Code)

                             (916) 941-1400
            --------------------------------------------------
           (Registrant's telephone number, including area code)












Securities registered pursuant to Section 12(b) of the Act:  None
Securities registered pursuant to Section 12(g) of the Act:  Limited
  Partnership Units


Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period
that the Registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.  Yes  X  No
                                                               ---    ---

Indicate by check mark whether the registrant is an accelerated filer (as
defined in Rule 12B-2 of the Act).                         Yes    No X
                                                              ---   ---

Indicate by check mark if disclosure of delinquent filers pursuant to
Item 405 of Regulation S-K is not contained herein, and will not be
contained, to the best of registrant's knowledge, in definitive proxy or
information statements incorporated by reference in Part III of this Form
10-K or any amendment to this Form 10-K. [   ]

No active market for the Units of limited partnership interests (Units)
exists, and therefore the market value of such Units cannot be
determined.

Documents incorporated by reference:  Portions of the Registrant's Proxy
Statement relating to the Registrant's Meeting of Limited Partners held
on November 8, 2002 are incorporated by reference into Part III of this
Form 10-K where indicated.



<PAGE>
                                   PART I

Item 1.  BUSINESS
------   --------

Technology Funding Venture Partners IV, An Aggressive Growth Fund,
L.P. (the Partnership or the Registrant) is a limited partnership
organized under the laws of the State of Delaware on December 4,
1986.  For the period from December 5, 1986, through November 14,
1988, the Partnership was inactive.  The Partnership filed a
registration statement with the Securities and Exchange Commission
on November 14, 1988, and commenced selling Units of limited
partnership interest (Units) in January 1989.  On February 16,
1989, the minimum number of Units required to commence Partnership
operations (15,000) had been sold.  The offering terminated with
400,000 Units sold on September 14, 1990.  The Partnership's
original contributed capital was $40,034,891, consisting of
$39,994,896 from Limited Partners for 400,000 Units and $39,995
from the General Partners, Technology Funding Ltd. (TFL) and
Technology Funding Inc. (TFI).  The General Partners do not own
any Units.

The principal investment objectives of the Partnership are long-
term capital appreciation from venture capital investments in new
and developing companies and preservation of Limited Partner
capital through risk management and active involvement with such
companies (portfolio companies).  The Partnership's investments in
portfolio companies primarily consist of equity securities such as
common and preferred shares, but also include debt convertible
into equity securities and warrants and options to acquire equity
securities.  Although venture capital investments offer the
opportunity for significant gains, such investments involve a high
degree of business and financial risk that can result in
substantial losses.  Among these are the risks associated with
investment in companies in an early stage of development or with
little or no operating history, companies operating at a loss or
with substantial variations in operating results from period to
period, and companies with the need for substantial additional
capital to support expansion or to achieve or maintain a
competitive position.  Such companies may face intense
competition, including competition from companies with greater
financial resources, more extensive development, manufacturing,
marketing and service capabilities, and a larger number of
qualified managerial and technical personnel.  There is no ready
market for many of the Partnership's investments.  The
Partnership's investments in portfolio companies are generally
subject to restrictions on sale because they were acquired from
the issuer in private placement transactions or because the
Partnership is an affiliate of the issuer.

The Partnership has elected to be a business development company
under the Investment Company Act of 1940, as amended (the Act),
and operates as a nondiversified investment company, as defined in
the Act.  The Partnership's term was extended for a two-year
period to December 31, 1999, pursuant to unanimous approval by the
Management Committee on December 5, 1997.  In April 1999, the
Management Committee further extended the term of the Partnership
to December 31, 2001.  At a special meeting on September 7, 2001,
the Limited Partners elected to extend the term of the Partnership
to December 31, 2002 and for up to three one-year extensions
through December 31, 2005.  On March 15, 2002, the Management
Committee unanimously approved a one-year extension of the
Partnership to December 31, 2003.  On November 8, 2002, the
Limited Partners approved an additional one-year extension of the
Partnership's term through December 31, 2006.  At the March 12,
2004, meeting, the Management Committee approved an extension of
the Partnership's term to December 31, 2006.

In December of 2005, the Management Committee and the Managing
General Partners adopted a plan of liquidation and began the
implementation thereof.  As part of the plan of liquidation and in
conjunction with the anticipated dissolution and then liquidation
of the Partnership, the Independent General Partners also approved
the retention of an independent third party to assist in the sale
of the Partnership's holdings.  On February 15, 2006, the
Independent General Partners approved a resolution directing the
Managing General Partners to notice a Special Meeting of the
Partnership at which meeting the Limited Partners would be asked
to vote upon a proposal to dissolve the Partnership prior to its
scheduled termination date of December 31, 2006, to place the
Partnership's assets and liabilities in a liquidating trust to be
formed for that purpose, and to withdraw the Partnership's
election as a Business Development Company under the 1940 Act.
Once the Liquidating Trust is formed and the Partnership's assets
and liabilities are transferred to the Liquidating Trust, the
Partnership shall be terminated for purposes of Delaware law and
the terms of the Liquidating Trust Agreement will govern
disposition of assets, proceeds and expenses.  Further, the
Managing General Partners have informed the Management Committee
that they are only willing to continue funding the Partnership's
operating expenditures through the completion of a prompt
liquidation (estimated to be three to six months).  Any proceeds
from the liquidation of the assets of the Partnership will be paid
first to creditors of the Partnership including the Managing
General Partners as provided in Section 15.02 of the Limited
Partnership Agreement.  The amount owed to the Managing General
Partners as creditors is expected to continue to increase until
proceeds from the sale of assets allow payments to all of the
creditors.  Unless the net proceeds from sale of the Partnership's
assets is substantially in excess of the aggregate estimated
liquidation values presented in the balance sheet, it is likely
that the sale proceeds will not be sufficient to meet the
Partnership's obligations to the creditors.  If that is the case,
the limited partners may receive no proceeds upon completion of
the liquidation process.  Absent timely liquidation events and
cash proceeds to support the continuing operation of the
Partnership, the Managing General Partners may accelerate
liquidation efforts to minimize further increases in the
obligations to creditors.  As of January 31, 2006, substantially
all of the publicly traded holdings had been liquidated.  As of
December 31, 2005, all of the Partnership's holdings in privately
held companies were valued at their estimated liquidation value.
Upon dissolution, the Partnership, whether by vote at the proposed
special meeting or by operation of the Partnership Agreement, will
go into liquidation and pursuant to the Partnership Agreement will
accrue all estimated liquidation costs and any future operating
costs including administrative and investor services, computer
services, record retention costs, professional fees and estimated
legal costs of the Partnership through final termination, as
provided for in the Partnership Agreement.  Based on prior
experience, management estimates it will take no more than three
to six months to liquidate all remaining investments.  In the
meantime, an Independent Third Party has been assisting in the
sale of Partnership holdings and will continue to solicit interest
in purchasing those holdings.  If no third party makes a bid
acceptable to the Liquidating Trustee (who shall be the Management
Committee, if still constituted, and otherwise shall be a Person
proposed and approved by a Majority in Interest of the Limited
Partners), the Managing General Partners may offer to acquire the
remaining assets from the Liquidating Trust for the fair value at
the time of the transaction.  From December 31, 2005, through
termination, the Partnership will continue to incur costs similar
to those experienced in prior years under normal operating
procedures except that there would be no charges related to
ongoing investment operations.

Item 2.  PROPERTIES
------   ----------

The Registrant has no material physical properties.

Item 3.  LEGAL PROCEEDINGS
------   -----------------

From time to time, the Partnership is subject to routine
litigation incidental to the business of the Partnership.
Although there can be no assurances as to the ultimate disposition
of these matters, it is the opinion of the Managing General
Partners, based upon the information available at this time, that
the expected outcome of these matters, individually or in the
aggregate, will not have a material adverse effect on the results
of operations and financial condition of the Partnership.

Item 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
------   ---------------------------------------------------

The following matters were voted on by the Limited Partners in
2005:

The election of two Independent General Partners each to serve for
a three-year term or until the earlier termination of the
Partnership;

The election of two Managing General Partners each to serve for a
three-year term or until the earlier termination of the
Partnership;

Ratification of the Independent General Partners' appointment of
Grant Thornton LLP as independent registered public accountants of
the Partnership.  After Grant Thornton subsequently terminated the
client-auditor relationship between the Partnership and Grant
Thornton, the Independent General Partners voted to ratify their
appointment of Heard, McElroy & Vestal, LLP (the Heard Group) as
independent registered public accountants of the Partnership.

                                 PART II

Item 5.  MARKET FOR REGISTRANT'S COMMON EQUITY AND RELATED STOCKHOLDER
------   -------------------------------------------------------------
         MATTERS
         -------

        (a) There is no established public trading market for the
            Units.

        (b) At December 31, 2005, there were 7,883 record holders of
            Units.

        (c) The Registrant, being a partnership, does not pay
            dividends.  Cash distributions, however, may be made to
            the partners pursuant to the Partnership Agreement.

<PAGE>


Item 6.  SELECTED FINANCIAL DATA
------   -----------------------

<TABLE>
<CAPTION>                                  For the Years Ended and As of December 31,
                                    ---------------------------------------------------------------
                                     2005           2004          2003          2002          2001
                                    ------         ------        ------        ------        ------
<S>                            <C>            <C>           <C>           <C>           <C>

Total investment income          $     955   $     2,112    $   11,567    $   29,278    $   78,566

Net investment loss             (1,844,813)   (2,192,864)   (1,604,234)   (1,401,764)   (1,488,740)

Net realized gain (loss) from
 sales of equity investments       137,192     2,037,463     1,632,882      (163,956)     (346,759)

Realized gain from
 venture capital limited
 partnership investments             3,836       141,428        73,406        18,036       295,343

Realized gain from recovery of
 investments previously
 written off                        86,037        98,111            --       356,841        47,540
Realized loss from
 investment write-offs             (29,840)     (991,146)     (316,239)   (4,848,611)   (1,615,883)

(Increase) decrease in
 unrealized depreciation:
  Equity investments            (2,166,726)    1,554,051     2,203,754    (2,249,130)   (3,171,163)
  Notes receivable                      --            --        10,437     4,874,425      (158,807)

Income from extinguishment
  of debt                               --       306,267            --       571,478            --

Other income                           314         8,473       193,830       774,298            --

Net (decrease) increase in
 partners' capital resulting
 from operations                (3,814,000)      961,783     2,193,836    (2,068,363)   (6,438,469)


Net (decrease) increase in
 partners capital resulting
 from operations per Unit            (7.67)       (0.11)         0.15         (4.36)       (13.08)

Total assets                     1,110,806     4,341,585     4,169,347     2,515,657     3,991,947



</TABLE>


Item 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
------   -------------------------------------------------
         CONDITION AND RESULTS OF OPERATIONS
         -----------------------------------

Liquidity and Capital Resources
-------------------------------

The Partnership operates as a business development company under
the Investment Company Act of 1940 and makes venture capital
investments in new and developing companies.  The Partnership's
financial condition is dependent upon the success of the
portfolio companies.  There is no ready market for many of the
Partnership's investments.  It is possible that some of its
venture capital investments may be a complete loss or may be
unprofitable and that others will appear likely to become
successful, but may never realize their potential.  The
valuation of the Partnership's investments in securities for
which there are no available market quotes is subject to the
estimate of the Managing General Partners in accordance with the
valuation guidance described in Note 1 to the financial
statements.  In the absence of readily obtainable market values,
the estimated fair value of the Partnership's investments may
differ significantly from the values that would have been used
had a ready market existed.  As described in Note 1 to the
financial statements, the Partnership is currently in
liquidation and all remaining investments are being carried at
their estimated liquidation value.

For the year ended December 31, 2005, net cash used by operating
activities totaled $1,878,529.  The Partnership paid management
fees of $30,892 to the Managing General Partners and reimbursed
related parties for operating expenses of $824,102 in 2005.  In
addition, $52,000 was paid to the Independent General Partners
as compensation for their services.  Advances of $1,080,974 were
made to Dakota Arms, Inc., a portfolio company, during the
period.  For the year ended December 31, 2005, the Partnership
funded equity investments of $300,000 to portfolio companies in
the medical/biotechnology industries.  Proceeds from equity
sales provided cash of $247,272.  The Partnership received cash
distributions from venture capital limited partnerships totaling
$18,996.  During 2005 the Partnership received $86,037 for
payment of notes receivable from RedCell, Inc. that had been
written off in 1998.  Interest income of $955 was received and
other net receipts were $56,179.

At December 31, 2005, there were no unfunded commitments.

Results of Operations
---------------------

2005 compared to 2004
---------------------

The net decrease in partners' capital resulting from operations
was $3,814,000 in 2005, compared to an increase of $961,783 in
2004.

During 2005, there were realized losses from investment write-
offs of $29,840, which represents the Partnership's total
investment in Onset Enterprises Associates, L.P.  During 2004,
the Partnership recorded realized losses from investment write-
offs of $991,146, which represents the Partnership's total
investment in WorldRes.com, Inc., Newtek Ventures II, L.P. and
Utah Ventures Limited Partnership.

Unrealized depreciation on equity investments was $2,571,290 and
$34,045 at December 31, 2005 and 2004, respectively.  During
2005, the decrease in unrealized depreciation of equity
investments of $2,166,726 was primarily attributable to
decreases in management's valuation of private portfolio
companies in the medical/biotechnology and retail/consumer
products industries.  During the year ended December 31, 2004,
the decrease in net unrealized depreciation on equity
investments of $1,554,051 was primarily a result of the write-
offs of WorldRes.com, Inc. and Newtek Ventures II, L.P., the
sales of iVillage Inc., Cypress Semiconductor Corporation and
Applied NeuroSolutions, Inc. and from an increase in the value
of Dakota Holdings, LLC.

In 2005 there was a net realized gain of $137,192, which
primarily resulted from the sales of Corautus Genetics Inc.,
Laser Diagnostics Technologies, Inc. and Icagen, Inc.  Net
realized gain from sales of equity investments totaled
$2,037,463 in 2004 and was primarily related to the sale of
Cypress Semiconductor Corporation.

During 2005, the Partnership recorded net realized gains from
venture capital limited partnership investments of $3,836
compared to gains of $141,428 during 2004.  The gains represent
distributions from profits of venture capital limited
partnerships.

In 2005 and 2004, the Partnership received $86,037 and $98,111
from RedCell, Inc., for notes receivable from the Partnership
that were previously written off.

On December 30, 2004, the Partnership turned over all of its
share holdings in Corautus Genetics Inc. to a financial
institution to satisfy the remaining balance on a note, and
recognized a gain from extinguishment of debt of $306,267,
resulting from the difference in fair value of the shares versus
the amount of debt outstanding.

Investment expenses were $1,845,768 and $2,194,976 for 2005 and
2004, respectively.

2004 compared to 2003
---------------------

Net increase in partners' capital resulting from operations was
$961,783 in 2004, compared to an increase of $2,193,836 in 2003.

Unrealized depreciation on notes receivable investments was $0
at December 31, 2004.  During the year ended December 31, 2003,
the net increase in unrealized depreciation of notes receivable
of $10,437 was primarily attributable to a decrease in the fair
value of notes issued to Avalon Visions Solutions, Inc.

During 2004, the Partnership recorded realized losses from
investment write-offs of $991,146, which represents the
Partnership's total investment in WorldRes.com, Inc., Newtek
Ventures II, L.P. and Utah Ventures Limited Partnership.  During
2003, there were realized losses from investment write-offs of
$316,239, which represents the Partnership's total investment in
Periodontix, Inc.

Unrealized depreciation on equity investments was $34,045 and
$1,588,096 at December 31, 2004 and 2003, respectively.  During
the year ended December 31, 2004, the decrease in net unrealized
depreciation on equity investments of $1,554,051 was primarily a
result of the write-offs of WorldRes.com, Inc. and Newtek
Ventures II, L.P., the sales of iVillage Inc., Cypress
Semiconductor Corporation and Applied NeuroSolutions, Inc. and
from an increase in the value of Dakota Holdings, LLC.  During
2003, the decrease in unrealized depreciation of equity
investments of $2,203,754 was primarily attributable to
decreases in the market prices of publicly traded portfolio
companies in the communications, environmental and
microelectronics industries.

Other income was $193,830 for the year ended December 31, 2003,
which was from the settlement of disputed legal fees related to
an arbitration settlement.

Net realized gain from sales of equity investments totaled
$2,037,463 in 2004 and was primarily related to the sale of
Cypress Semiconductor Corporation.  In 2003 there was a net
realized gain of $1,632,882, which primarily resulted from the
sale of KOR Electronics, Inc.

During 2004, the Partnership recorded net realized gains from
venture capital limited partnership investments of $141,428
compared to gains of $73,406 during 2003.  The gains represent
distributions from profits of venture capital limited
partnerships.

In 2004, the Partnership received a $98,111 payment from
RedCell, Inc., subsequently ConjuChem, Inc., for notes
receivable from the Partnership that were previously written
off.

On December 30, 2004, the Partnership turned over all of its
share holdings in Corautus Genetics Inc. to a financial
institution to satisfy the remaining balance on a note and
recognized a gain from extinguishment of debt of $306,267,
resulting from the difference in fair value of the shares versus
the amount of debt outstanding.

Investment expenses were $2,194,976 and $1,615,801 for 2004 and
2003, respectively.

Item 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK
-------  ----------------------------------------------------------

The Partnership is subject to financial market risks, including
changes in interest rates with respect to its investments in
debt securities and interest-bearing cash equivalents as well as
changes in marketable equity security prices.  The Partnership
does not use derivative financial instruments to mitigate any of
these risks.  The return on the Partnership's investments is
generally not affected by foreign currency fluctuations.

The Partnership does not have a significant exposure to public
market price fluctuations as the Partnership primarily invests
in private business enterprises.  However, should significant
changes in market equity prices occur, there could be a longer-
term effect on valuations of private companies, which could
affect the carrying value and the amount and timing of gains or
losses realized on these investments.  Since there is typically
no public market for the Partnership's investments in private
companies, the valuation of the investments is subject to the
estimate of the Partnership's Managing General Partners.  In the
absence of a readily ascertainable market value, the estimated
value of the Partnership's investments in private companies may
differ significantly from the values that would be placed on the
portfolio if a ready market existed. The Partnership's portfolio
also includes common stocks in publicly traded companies.  These
investments are directly exposed to equity price risk, in that a
hypothetical 10 percent change in these equity prices would
result in a similar percentage change in the fair value of these
securities.  The Partnership's investments also include some
debt securities.  Since the debt securities are generally priced
at a fixed rate, changes in interest rates do not directly
impact interest income.  The Partnership's debt securities are
generally held to maturity or converted into equity securities
of private companies.  As described in Note 1 to the financial
statements, the Partnership is currently in liquidation and all
remaining investments are being carried at their estimated
liquidation value.

Item 8.  FINANCIAL STATEMENTS
------   --------------------

The financial statements of the Registrant are set forth in Item
15.

Item 9.  CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING
------   -----------------------------------------------------------
         AND FINANCIAL DISCLOSURE
         ------------------------

On August 18, 2005, Technology Funding Partners III, L.P., (the
"Partnership") filed a Current Report on Form 8-K/A disclosing
that on August 16, 2005, Grant Thornton LLP (Grant Thornton)
terminated the client-auditor relationship between Grant
Thornton and the Partnership.

There were no disagreements with the Partnership's former
accountants, Grant Thornton, on any matter of accounting
principles, financial statement disclosure, or auditing scope or
procedure for the two years ended December 31, 2004, and the
subsequent interim period through the date of termination.

On October 24, 2005, the chairman of the Partnership's Audit
Committee approved the retention of the Heard Group as the
Partnership's independent registered accounting firm.  The
Partnership has not consulted with the Heard Group regarding the
application of accounting principles to a specific completed or
contemplated transaction, or the type of audit opinion that
might be rendered on the Partnership's financial statements, or
any other matter set forth in Item 304 (a) (2) of Regulation S-K
(Reg. ss. 229.304 (a) (2)) during the last two fiscal years or
thereafter through the date of this report, and no written or
oral advice was provided that was an important factor considered
by the Partnership in reaching a decision as to any accounting,
auditing, or financial reporting issue.

Item 9A. CONTROLS AND PROCEDURES
-------  -----------------------

The signing officer is responsible for establishing and
maintaining disclosure controls and procedures for Technology
Funding Venture Partners IV, An Aggressive Growth Fund, L.P.
Such officer has concluded (based upon his evaluation of these
controls and procedures as of a date within 90 days of the
filing of this report) that Technology Funding Venture Partners
IV, An Aggressive Growth Fund, L.P.'s disclosure controls and
procedures are effective to ensure that information required to
be disclosed by Technology Funding Venture Partners IV, An
Aggressive Growth Fund, L.P. in this report is accumulated and
communicated to Technology Funding Venture Partners IV, An
Aggressive Growth Fund, L.P.'s management, including its
principal executive officers as appropriate, to allow timely
decisions regarding required disclosure.

The certifying officer also has indicated that there were no
significant changes in Technology Funding Venture Partners IV,
An Aggressive Growth Fund, L.P.'s internal controls or other
factors that could significantly affect such controls subsequent
to the date of their evaluation, and there were no corrective
actions with regard to significant deficiencies and material
weaknesses.

                               PART III

Item 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT
-------  --------------------------------------------------

As a partnership, the Registrant has no directors or executive
officers.  The Management Committee is responsible for the
management and administration of the Partnership.  The members
of the Management Committee consist of the two Independent
General Partners and a representative from Technology Funding
Ltd., a California limited partnership (TFL).  TFL and its
wholly owned subsidiary, Technology Funding Inc., a California
corporation (TFI), are the Managing General Partners.  Reference
is made to the information regarding Independent General
Partners and the Managing General Partners in the Registrant's
Proxy Statement related to the Meeting of Limited Partners held
on May 20, 2005, which information is incorporated herein by
reference.

Code of Ethics
--------------

The Partnership's Code of Ethics applies to the Independent
General Partners as well as Technology Funding corporate
officers and employees.  The Independent General Partners review
and approve the Code of Ethics on an annual basis.  The Code of
Ethics is attached as an exhibit (see Item 15 - Exhibits) and is
also available on the Partnership's web site,
www.techfunding.com.  Any amendments to, or waivers from, any
provision of the Code that applies to any of the Independent
General Partners or executive officers will be disclosed on the
web site.

Audit Committee
---------------

As of December 31, 2004, the Independent General Partners had
established an Audit Committee of the Whole to oversee the
accounting and financial reporting processes on behalf of the
Independent General Partners. The Audit Committee of the Whole
consisted of all of the Independent General Partners for each
Technology Funding partnership with John W. Muncaster acting as
liaison with the Managing General Partners.  On March 11, 2005,
the Independent General Partners restructured the Audit
Committee of the Whole.  An Audit Committee was established
whereby John W. Muncaster, an Independent General Partner, will
serve as Audit Committee Chairman with the remaining Independent
General Partner serving as an Audit Committee member.  The
Independent General Partners are  "independent" as defined by
the Securities and Exchange Commission.  The Independent General
Partners have determined that the Audit Committee and the Audit
Committee of the Whole did not have any member that would be
considered an "audit committee financial expert" as that term is
defined in Section 407 of the Sarbanes-Oxley Act of 2002.  Given
the anticipated termination date for the Partnership, the
Independent General Partners have determined that the expense
and the difficulty of recruiting a financial expert to serve on
the Audit Committee outweigh any benefit to the Fund.

Item 11. EXECUTIVE COMPENSATION
-------  ----------------------

The Registrant has no officers, directors or employees.  In
2005, the Partnership incurred management fees of $28,121.  The
fees are designed to compensate the Managing General Partners
for General Partner Overhead incurred in performing management
duties for the Partnership.  General Partner Overhead (as
defined in the Partnership Agreement) includes the General
Partners' share of rent, utilities, property taxes and the cost
of capital equipment and the general and administrative expenses
paid by Managing General Partners in performing their
obligations to the Partnership.  The Partnership is governed by
a Management Committee that consists of the Independent General
Partners and one representative from the Managing General
Partners.  As compensation for their services, each of the
Independent General Partners receive $14,000 annually plus
$1,500 for each attended meeting of the Management Committee and
committees thereof.  In 2005, $52,000 in aggregate of such
compensation was paid.  The Independent General Partners are
reimbursed for all out-of-pocket expenses relating to attendance
of the meetings, committees or otherwise of the Management
Committee.  As disclosed in Footnote 3, the Managing General
Partners are reimbursed for expenses related to providing
services to the Partnership including compensation to
individuals who are officers or partners of the Managing General
Partners; such persons are not officers, directors, or employees
of the Partnership and receive no direct compensation from the
Partnership.

Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
-------  --------------------------------------------------------------

Not applicable.  No Limited Partner beneficially holds more than
5 percent of the aggregate number of Units held by all Limited
Partners, and neither the Managing General Partners nor any of
their officers, directors or partners own any Units.  The two
Independent General Partners each own 20 Units.  The Management
Committee controls the affairs of the Partnership pursuant to
the Partnership Agreement.

Item 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
-------  ----------------------------------------------

The Registrant, or its investee companies, have engaged in no
transactions with the Managing General Partners or their
officers and partners other than as described above, in the
notes to the financial statements, or in the Partnership
Agreement.

Item 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
-------  --------------------------------------

Audit Fees
----------

The Partnership paid aggregate fees of approximately $90,421 and
$72,202 to its independent public accountants, the Heard Group
and Grant Thornton LLP, for professional services rendered to
the Partnership with respect to audits of the annual financial
statements and reviews of the quarterly financial statements for
the years ended December 31, 2005 and 2004, respectively.

Tax Fees
--------

The Partnership paid aggregate fees of approximately $22,216 and
$19,778 to WTAS, Inc., and Grant Thornton LLP for tax-related
services rendered to the Partnership for the years ended
December 31, 2005 and 2004, respectively.  These services
included preparation of the Partnership's tax returns.

All Other Fees
--------------

The Partnership did not pay any fees to the Heard Group, WTAS,
Inc., or Grant Thornton LLP for services, other than the
services referred to above, for the years ended December 31,
2005 and 2004, respectively.

Audit Committee Pre-Approval Policies and Procedures
----------------------------------------------------

The Independent General Partners have established procedures for
the pre-approval of auditing services and non-auditing services
to be performed by the Partnership's independent public
accountants.  Such pre-approval can be given as part of the
Independent General Partners' annual approval of the scope of
the engagement of the independent public accountants or on an
individual basis.  Approved non-auditing services must be
disclosed in the Partnership's periodic public reports.  The
Independent General Partners pre-approved all of the non-audit
services provided by the independent public accountants in 2003.

                               PART IV

Item 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES
-------  ---------------------------------------

         (a)  List of Documents filed as part of this Annual Report on
               Form 10-K

             (1)  Financial Statements - the following financial
                   statements are filed as a part of this Report:

Reports of Independent Registered Public Accounting
Firms as of December 31, 2005 and 2004 and for the
three years ended December 31, 2005.
                  Balance Sheets as of December 31, 2005 and 2004
                  Statements of Investments as of
                   December 31, 2005 and 2004
                  Statements of Operations for the years
                   ended December 31, 2005, 2004 and 2003
                  Statements of Partners' Capital for the years
                   ended December 31, 2005, 2004 and 2003
                  Statements of Cash Flows for the years
                   ended December 31, 2005, 2004 and 2003
                  Notes to Financial Statements

             (2)  Financial Statement Schedules

                  All schedules have been omitted because they are
                   not applicable or the required information is
                   included in the financial statements or the notes
                   thereto.

             (3)  Exhibits

                   14.1  Code of Ethics for the Registrant
                   31.1  Section 302 Sarbanes-Oxley Certifications
                   32.1  Section 906 Sarbanes-Oxley Certifications




<PAGE>

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
-------------------------------------------------------
To the Partners of
     Technology Funding Venture Partners IV,
      an Aggressive Growth Fund, L.P.:


We have audited the accompanying balance sheet of Technology Funding
Venture Partners IV, an Aggressive Growth Fund, L.P. (a Delaware limited
partnership, in process of liquidation) (the Partnership), including the
statement of investments, as of December 31, 2005, and the related
statements of operations, partners' capital and cash flows for the year
then ended. These financial statements are the responsibility of the
Partnership's management. Our responsibility is to express an opinion on
these financial statements based on our audit.

We conducted our audit in accordance with the standards of the Public
Company Accounting Oversight Board (United States). Those standards
require that we plan and perform the audit to obtain reasonable assurance
about whether the financial statements are free of material misstatement.
The Partnership is not required to have, nor were we engaged to perform,
an audit of its internal control over financial reporting. Our audit
included consideration of internal control over financial reporting as a
basis for designing audit procedures that are appropriate in the
circumstances, but not for the purpose of expressing an opinion on the
effectiveness of the Partnership's internal control over financial
reporting. Accordingly, we express no such opinion. An audit also
includes examining, on a test basis, evidence supporting the amounts and
disclosures in the financial statements, assessing the accounting
principles used and significant estimates made by management, as well as
evaluating the overall financial statement presentation. Our procedures
included physical inspection of securities owned as of December 31, 2005.
We believe our audit provides a reasonable basis for our opinion.

As described in Note 1 to the financial statements, in December 2005, the
Management Committee and the Managing General Partners of the Partnership
adopted a plan of liquidation and began the implementation thereof. As
part of the plan of dissolution and then liquidation of the Partnership,
the Independent General Partners also approved the retention of an
independent third party to assist in the sale of the Partnership's
holdings. Further, the Managing General Partners have informed the
Management Committee that they are only willing to continue funding the
Partnership's operating expenditures through the completion of a prompt
liquidation (estimated to be three to six months). As a result, as of
December 31, 2005, the Partnership changed its basis of accounting to the
liquidation basis. Accordingly, the carrying values of the remaining
assets as of December 31, 2005, are presented at estimated realizable
value assuming prompt liquidation as determined by the Management
Committee. It is possible that these estimates and the amount of time
required to liquidate the remaining investments will change as the
Managing General Partners gain additional information from their efforts
to sell the remaining investments and from information provided by the
third party retained to assist in selling the assets. We have reviewed
the procedures applied by the Managing General Partners under the
direction of the Management Committee in valuing such assets and have
inspected underlying documentation; while in the circumstances the
procedures appear to be reasonable and the documentation appropriate,
determination of liquidation values involves subjective judgment which is
not susceptible to substantiation by auditing procedures.

In our opinion, subject to the effect on the financial statements of the
valuation of the remaining assets by the Managing General partners under
the direction of the Management Committee as described in the preceding
paragraph, the financial statements referred to above present fairly, in
all material respects, the financial position of Technology Funding
Venture Partners IV, an Aggressive Growth Fund, L.P. as of December 31,
2005, and the results of its operations, changes in partners' capital,
and its cash flows for the year then ended, in conformity with accounting
principles generally accepted in the United States of America applied on
the basis described in the preceding paragraph.


_______________________               /S/  HEARD, MCELROY, VESTAL, LLP
Shreveport, Louisiana
March 20, 2006


<PAGE>

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
-------------------------------------------------------
To the Partners of
     Technology Funding Venture Partners IV,
      an Aggressive Growth Fund, L.P.:


We have audited the accompanying balance sheets of Technology Funding
Venture Partners IV, an Aggressive Growth Fund, L.P. (a Delaware limited
partnership) (the Fund), including the statement of investments, as of
December 31, 2004, and the related statements of operations, partners'
capital, and cash flows for each of the two years in the period ended
December 31, 2004.  These financial statements are the responsibility of
the Fund's management. Our responsibility is to express an opinion on
these financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public
Company Accounting Oversight Board (United States).  Those standards
require that we plan and perform the audit to obtain reasonable assurance
about whether the financial statements are free of material misstatement.
The Company is not required to have, nor were we engaged to perform an
audit of its internal control over financial reporting.  Our audits
included consideration of internal control over financial reporting as a
basis for designing audit procedures that are appropriate in the
circumstances, but not for the purpose of expressing an opinion on the
effectiveness of the Company's internal control over financial reporting.
Accordingly, we express no such opinion.  An audit also includes
examining, on a test basis, evidence supporting the amounts and
disclosures in the financial statements, assessing the accounting
principles used and significant estimates made by management, as well as
evaluating the overall financial statement presentation.  Our procedures
included physical inspection of securities owned as of December 31, 2004.
We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present
fairly, in all material respects, the financial position of Technology
Funding Venture Partners IV, an Aggressive Growth Fund, L.P. as of
December 31, 2004, and the results of its operations, changes in
partners' capital, and its cash flows for the two years in the period
ended December 31, 2004 in conformity with accounting principles
generally accepted in the United States of America.


Albuquerque, New Mexico                      /S/GRANT THORNTON LLP
March 11, 2005






<PAGE>

BALANCE SHEETS
--------------
<TABLE>
<CAPTION>
                                                   December 31,
                                            ------------------------
                                             2005              2004
                                            ------            ------
<S>                                      <C>              <C>
ASSETS

Investments:
  Equity investments (cost basis of
   $3,615,689 and $2,165,201 for
   2005 and 2004, respectively)         $1,044,399        $2,131,156

Cash and cash equivalents                    2,795         1,881,324
Prepaid expenses                            60,115           100,159
Due from portfolio company                      --           224,594
Other assets                                 3,497             4,352
                                         ---------         ---------
       Total assets                     $1,110,806        $4,341,585
                                         =========         =========

LIABILITIES AND PARTNERS' CAPITAL

Accounts payable and accrued expenses   $   36,240        $   21,274
Due to related parties                     832,014           263,759
Other liabilities                            3,353             3,353
                                         ---------         ---------
       Total liabilities                   871,607           288,386

Commitments and contingencies
   (See Note 10)

Partners' capital
 (400,000 Limited Partner Units
  outstanding)                             239,199         4,053,199
                                         ---------         ---------
       Total liabilities and
        partners' capital               $1,110,806        $4,341,585
                                         =========         =========
</TABLE>

The accompanying notes are an integral part of these financial
statements.


STATEMENTS OF INVESTMENTS
-------------------------
<TABLE>
<CAPTION>
                                         Principal
                                         Amount or   December 31, 2005       December 31, 2004
Industry                                 Shares at   -----------------       -----------------
(1)                         Investment  December 31, Cost       Fair         Cost        Fair
Company           Position  Date          2005       Basis      Value        Basis       Value
-------------     --------  ----------  -----------  -----      -----        -----       -----
<S>                <C>         <C>      <C>         <C>        <C>          <C>        <C>
Equity Investments
------------------

SHORT TERM INVESTMENTS
----------------------

PRIVATELY HELD SECURITIES AVAILABLE FOR IMMEDIATE SALE
------------------------------------------------------

Medical/Biotechnology
---------------------
192.7% and 6.6% at December 31, 2005 and 2004, respectively
-----------------------------------------------------------
Sanarus
 Medical,          Preferred    1999-
 Inc. (a) (b)      shares       2005     776,288   $ 947,670  $ 460,913  $  647,671  $ 268,860
                                                   ---------  ---------  ----------  ---------

PUBLIC SECURITIES AVAILABLE FOR IMMEDIATE SALE
----------------------------------------------

Retail / Consumer Products
--------------------------
0.0% and 0.0% at December 31, 2005 and 2004, respectively
---------------------------------------------------------
Lifestyle
 Innovations,      Preferred
 Inc. (a) (b)      shares       2004           0         --          --          --         25
                                                   --------   ---------   ---------   --------

STATEMENTS OF INVESTMENTS (continued)
--------------------------------------------

Environmental
-------------
0.0% and 0.0% at December 31, 2005 and 2004, respectively
-----------------------------------------------------------
Various
 investments       various      1999     various      10,614         --      10,614         --
                                                   ---------  ---------  ----------  ---------

Medical Biotechnology
---------------------
0.0% and 3.5% at December 31, 2005 and 2004, respectively
-----------------------------------------------------------
Various
 investments       various      2004           0          --         --     110,079    143,070
                                                   ---------  ---------  ----------  ---------

Retail / Consumer Products
--------------------------
243.9% and 39.7% at December 31, 2005 and 2004, respectively
---------------------------------------------------------
Dakota             LLC          2003-
 Holdings, LLC (a) units        2004   1,614,638   2,165,888    565,121     879,638  1,539,367
Various
 investments       various (2)  2004      41,430      91,821     18,365      72,503     72,525
                                                   ---------    -------     -------  ---------
                                                   2,257,709    583,486     952,141  1,611,892
Venture Capital Limited Partnership Investments
-----------------------------------------------
0.0% and 2.6% at December 31, 2005 and 2004, respectively
---------------------------------------------------------
Various            Ltd.
 investments       Partnership
                   interests  various   various      399,696        --      444,696    107,309
                                                   ---------  ---------  ----------  ---------


Total investments - 436.6% and 52.6% at
 December 31, 2005 and 2004, respectively         $3,615,689 $1,044,399 $ 2,165,201 $2,131,156
                                                   =========  =========  ==========  =========

Legends and footnotes:

--  No investment held at end of period.
 0  Investment active with a cost basis or fair value of zero.

(a) Equity security acquired in a private placement transaction; resale may be subject to
certain selling restrictions.
(b) Portfolio company is an affiliate of the Partnership; resale may be subject to certain
selling restrictions.
(c) Security is pledged as collateral for borrowing for 2003.  (See Note 8.)

(1) Represents the total fair value of a particular industry segment as a percentage of
partners' capital at 12/31/05 and 12/31/04.

(2) The Partnership has no income-producing equity investments except for convertible notes
which include accrued interest.  Interest rates on such notes are 4.79 percent.

</TABLE>

The accompanying notes are an integral part of these financial statements.



<PAGE>
STATEMENTS OF OPERATIONS
------------------------
<TABLE>
<CAPTION>

                                    For the Years Ended December 31,
                                  -----------------------------------
                                   2005          2004           2003
                                  ------        ------         ------
<S>                          <C>           <C>            <C>

Investment income:
 Notes receivable
  interest                    $       --   $        --   $    11,008
 Short-term investment
  interest                           955         2,112           559
                               ---------     ---------     ---------
    Total investment
     income                          955         2,112        11,567

Investment expenses:
 Management fees                  28,121        44,690        32,924
 Independent General
  Partners' compensation          52,000        70,625        40,000
 Investment operations           248,570       392,279       169,067
 Administrative and
  investor services              884,271     1,429,842     1,088,162
 Computer services                91,963       142,891       106,107
 Professional fees               170,324        96,868       163,857
 Interest expense                     --        17,781        15,684
 Bad debt expense                370,519            --            --
                                ---------      --------     ---------
    Total investment
     expenses                  1,845,768     2,194,976     1,615,801
                               ---------     ---------     ---------
Net investment loss           (1,844,813)   (2,192,864)   (1,604,234)
                               ---------     ---------     ---------
 Realized gain from
  venture capital limited
  partnership investments          3,836       141,428        73,406
 Net realized gain
  from sales of equity
  investments                    137,192     2,037,463     1,632,882
 Realized gain from recovery
  of investments previously
  written off                     86,037        98,111            --
 Realized loss from
  investment write-offs          (29,840)     (991,146)     (316,239)
                               ---------     ---------     ---------
Net realized gain                197,225     1,285,856     1,390,049
                               ---------     ---------     ---------


STATEMENTS OF OPERATIONS (continued)
-----------------------------------
                                    For the Years Ended December 31,
                                  -----------------------------------
                                   2005          2004           2003
                                  ------        ------         ------
<S>                          <C>             <C>           <C>
 (Increase) decrease in
 unrealized depreciation:
  Equity investments          (2,166,726)    1,554,051     2,203,754
  Notes receivable                    --            --        10,437
                               ---------     ---------     ---------
Net (increase) decrease in
 unrealized depreciation      (2,166,726)    1,554,051     2,214,191
                               ---------     ---------     ---------

Other income:
  Income from extinguishment
   of debt                            --       306,267            --
  Other income                       314         8,473       193,830
                               ---------     ---------     ---------
     Total other income              314       314,740       193,830
                               ---------     ---------     ---------

Net (decrease) increase in
 partners' capital resulting
 from operations             $(3,814,000)  $   961,783   $ 2,193,836
                               =========     =========     =========
Net (decrease) increase in
 partners' capital resulting
  from operations per Unit     $    (7.67)  $     (0.11)  $      0.15
                               =========     =========     =========

</TABLE>















The accompanying notes are an integral part of these financial statements.



<PAGE>
STATEMENTS OF PARTNERS' CAPITAL
-------------------------------
<TABLE>
<CAPTION>
For the years ended December 31, 2005, 2004 and 2003:

                                   Limited     General
                                   Partners    Partners     Total
                                   --------    --------     -----
<S>                              <C>         <C>         <C>
Partners' capital,
    January 1, 2003                 $5,353,131 $(3,756,998)  $1,596,133

Net investment loss                      --  (1,604,234)  (1,604,234)
Net realized income                  59,323   1,330,724    1,390,047
Net decrease in unrealized
 depreciation                            --   2,214,191    2,214,191
Other income                             --     193,830      193,830
Distributions                            --    (698,551)    (698,551)
                                  ---------   ---------    ---------
Partners' capital,
  December 31, 2003               5,412,454  (2,321,038)   3,091,416

Net investment loss                      --  (2,192,864)  (2,192,864)
Net realized income                 (44,103)  1,329,959    1,285,856
Net increase in unrealized
 depreciation                            --   1,554,051    1,554,051
Other income                             --     314,740      314,740
                                 ----------   ---------    ---------
Partners' capital,
 December 31, 2004                5,368,351  (1,315,152)   4,053,199

Net investment loss              (1,475,599)   (369,214)  (1,844,813)
Net realized loss                   152,839      44,386      197,225
Net decrease in unrealized
 depreciation                    (1,745,220)   (421,506)  (2,166,726)
Other income                             --         314          314
                                  ---------   ---------    ---------
Partners' capital,
  December 31, 2005              $2,300,371 $(2,061,172)  $  239,199
                                  =========   =========    =========

</TABLE>



The accompanying notes are an integral part of these financial
statements.


<PAGE>
STATEMENTS OF CASH FLOWS
------------------------
<TABLE>
<CAPTION>
                                     For The Years Ended December 31,
                                    ---------------------------------
                                      2005         2004        2003
                                    --------     --------    --------
<S>                           <C>          <C>           <C>
Net increase (decrease) in
 partners' capital resulting
 from operations                 $(3,814,000) $   961,783  $ 2,193,836

Adjustments to reconcile net
 increase (decrease) in
 partners' capital resulting
 from operations to net cash
 used by operating activities:
  Bad debt expense                   370,519           --           --
  Net realized gain from
   venture capital limited
   partnership investments            (3,836)    (141,428)     (73,406)
  Net realized (gain) loss from
   sales of equity investments      (137,192)  (2,037,463)  (1,632,882)
  Realized loss from
   investment write-offs              29,840      991,146      316,239
  Realized gain from recovery
   of investments previously
   written off                       (86,037)     (98,111)          --
  Income from extinguishment
   of debt                                --     (306,267)          --
  Net increase (decrease) in
   unrealized depreciation:
    Equity investments             2,166,726   (1,554,051)  (2,203,754)
    Notes receivable                      --           --      (10,437)
  Net change in operating assets
   and liabilities:
    Accrued interest on notes
     receivable                           --       (1,256)       3,046
    Prepaid expenses                  40,044       40,044       40,044
    Receivables from related
     party                                --      811,612     (811,609)
    Due from portfolio company    (1,080,974)    (224,594)          --
    Other receivable                      --       68,323      705,975
    Accounts payable and
     accrued expenses                 14,966       22,817       (3,360)
    Due to related parties           568,255     (164,611)     146,082
    Other changes, net                   855      (22,600)      13,005
    Purchase of equity investments  (300,000)    (340,569)  (1,182,433)
    Repayment of notes receivable         --           --       85,204
    Proceeds from recovery of
     investments previously
     written off                      86,037       98,111           --
    Proceeds from sales of
     equity investments              247,272    3,527,346    3,126,521

 STATEMENTS OF CASH FLOWS (continued)
-------------------------------------

                                     For The Years Ended December 31,
                                    ---------------------------------
                                      2005         2004        2003
                                    --------     --------    --------
<S>                               <C>          <C>          <C>
Distributions from venture
 capital limited partnership
 investments                           18,996      141,428       73,405
                                    ---------    ---------    ---------
    Net cash (used) provided by
     operating activities          (1,878,529)   1,771,660      785,746
                                    ---------    ---------    ---------
Cash flows from financing
 activities:
  Distributions to General
    Partners                               --           --     (698,551)
                                    ---------    ---------    ---------
    Net cash (used) provided by
     financing activities                  --           --     (698,551)
                                    ---------    ---------    ---------
Net (decrease) increase in cash
 And cash equivalents              (1,878,529)   1,771,660       86,925

Cash and cash equivalents
 at beginning of year               1,881,324      109,664       22,739
                                    ---------    ---------    ---------
Cash and cash equivalents
 at end of year                    $    2,795   $1,881,324  $   109,664
                                    =========    =========    =========
Supplemental disclosure of
 non-cash activity:
  Extinguishment of debt for
   shares in equity
   investment (See Note 8)         $       --   $  626,509  $        --
                                    =========    =========   ==========
  Conversion of due from
   portfolio company, net to
   investments                     $  935,049   $       --  $        --
                                    =========    =========   ==========






</TABLE>
The accompanying notes are an integral part of these financial statements.






<PAGE>

NOTES TO FINANCIAL STATEMENTS
-----------------------------

1.  Summary of Significant Accounting Policies
    ------------------------------------------

Organization
------------

Technology Funding Venture Partners IV, An Aggressive Growth Fund, L.P.
(the Partnership or the Registrant) is a limited partnership organized
under the laws of the State of Delaware on December 4, 1986.  The purpose
of the Partnership is to make venture capital investments in new and
developing companies.  The Partnership elected to be treated as a business
development company under the Investment Company Act of 1940, as amended
(the Act), and operates as a nondiversified investment company, as defined
in the Act.  The Managing General Partners are Technology Funding Ltd.
(TFL) and Technology Funding Inc. (TFI), a wholly owned subsidiary of TFL.
There are also two Independent General Partners.  The Independent General
Partners and a representative from TFL constitute the Management Committee,
which is responsible for the management and administration of the
Partnership.

For the period from December 5, 1986, through November 14, 1988, the
Partnership was inactive.  The Partnership's registration statement was
declared effective by the Securities and Exchange Commission on November
14, 1988, and the Partnership commenced selling Units of limited
partnership interests (Units) on January 10, 1989.  On February 16, 1989,
the minimum number of Units required to commence Partnership operations
(15,000) were sold.  The offering terminated with 400,000 Units sold on
September 14, 1990.  The Partnership's original contributed capital was
$40,034,891, consisting of $39,994,896 from Limited Partners for 400,000
Units and $39,995 from General Partners.  The General Partners do not own
any Units.  The Partnership's term was extended for a two-year period to
December 31, 1999, pursuant to unanimous approval by the Management
Committee on December 5, 1997.  In April 1999, the Management Committee
further extended the term of the Partnership to December 31, 2001.  At a
special meeting on September 7, 2001, the Limited Partners elected to
extend the term of the Partnership to December 31, 2002, and for up to
three one-year extensions through December 31, 2005.  On March 15, 2002,
the Management Committee unanimously approved a one-year extension of the
Partnership to December 31, 2003.  On November 8, 2002, the Limited
Partners approved an additional one-year extension of the Partnership's
term to December 31, 2006, at the discretion of the Management Committee.
At the March 12, 2004, meeting, the Management Committee approved an
extension of the Partnership's term to December 31, 2006.

Liquidation of the Partnership
------------------------------

In December of 2005, the Management Committee and the Managing General
Partners adopted a plan of liquidation and began the implementation
thereof.  As part of the plan of liquidation and in conjunction with the
anticipated dissolution and then liquidation of the Partnership, the
Independent General Partners also approved the retention of an independent
third party to assist in the sale of the Partnership's holdings.  On
February 15, 2006, the Independent General Partners approved a resolution
directing the Managing General Partners to notice a Special Meeting of the
Partnership at which meeting the Limited Partners would be asked to vote
upon a proposal to dissolve the Partnership prior to its scheduled
termination date of December 31, 2006, to place the Partnership's assets
and liabilities in a liquidating trust to be formed for that purpose, and
to withdraw the Partnership's election as a Business Development Company
under the 1940 Act.  Once the Liquidating Trust is formed and the
Partnership's assets and liabilities are transferred to the Liquidating
Trust, the Partnership shall be terminated for purposes of Delaware law and
the terms of the Liquidating Trust Agreement will govern disposition of
assets, proceeds and expenses.  Further, the Managing General Partners have
informed the Management Committee that they are only willing to continue
funding the Partnership's operating expenditures through the completion of
a prompt liquidation (estimated to be three to six months).  Any proceeds
from the liquidation of the assets of the Partnership will be paid first to
creditors of the Partnership including the Managing General Partners as
provided in Section 15.02 of the Limited Partnership Agreement.  The amount
owed to the Managing General Partners as creditors is expected to continue
to increase until proceeds from the sale of assets allow payments to all of
the creditors.  Unless the net proceeds from sale of the Partnership's
assets is substantially in excess of the aggregate estimated liquidation
values presented in the balance sheet, it is likely that the sale proceeds
will not be sufficient to meet the Partnership's obligations to the
creditors.  If that is the case, the limited partners may receive no
proceeds upon completion of the liquidation process.  Absent timely
liquidation events and cash proceeds to support the continuing operation of
the Partnership, the Managing General Partners may accelerate liquidation
efforts to minimize further increases in the obligations to creditors.  As
of January 31, 2006, substantially all of the publicly traded holdings had
been liquidated.  As of December 31, 2005, all of the Partnership's
holdings in privately held companies were valued at their estimated
liquidation value.  Upon dissolution, the Partnership, whether by vote at
the proposed special meeting or by operation of the Partnership Agreement,
will go into liquidation and pursuant to the Partnership Agreement will
accrue all estimated liquidation costs and any future operating costs
including administrative and investor services, computer services, record
retention costs, professional fees and estimated legal costs of the
Partnership through final termination, as provided for in the Partnership
Agreement.  Based on prior experience, management estimates it will take no
more than three to six months to liquidate all remaining investments.  In
the meantime, an Independent Third Party has been assisting in the sale of
Partnership holdings and will continue to solicit interest in purchasing
those holdings.  If no third party makes a bid acceptable to the
Liquidating Trustee (who shall be the Management Committee, if still
constituted, and otherwise shall be a Person proposed and approved by a
Majority in Interest of the Limited Partners), the Managing General
Partners may offer to acquire the remaining assets from the Liquidating
Trust for the fair value at the time of the transaction.  From December 31,
2005, through termination, the Partnership will continue to incur costs
similar to those experienced in prior years under normal operating
procedures except that there would be no charges related to ongoing
investment operations.

Preparation of Financial Statements and Use of Estimates
--------------------------------------------------------

The accompanying financial statements have been prepared on the accrual
basis of accounting of a partnership in liquidation.  The preparation of
financial statements in conformity with accounting principles generally
accepted in the United States requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the
financial statements and the reported amounts of income and expenses during
the reporting period.  Actual results could differ from those estimates.
Significant estimates include the estimate of fair value of investments,
liabilities and contingencies.  Because of the inherent uncertainty of
valuation, the estimated fair value of investments may differ significantly
from the values that would have been used had a ready market for
investments existed, and the differences could be material.

Investments
-----------

Investments are carried at estimated liquidation amounts, which management
believes approximate estimated fair value as determined below:

Equity Investments
------------------

The Management Committee has the authority to establish valuation
procedures and periodically apply such procedures to the Partnership's
investment portfolio.  In fulfilling this responsibility, the Managing
General Partners under the direction of the Management Committee
periodically update and revise the valuation procedures used to determine
fair value in order to reflect new events, changing market conditions, more
experience with investee companies or additional information, any of which
may require the revision of previous estimating procedures.

Unrestricted publicly traded securities are valued at the closing sales
price or bid price that is available on a national securities exchange or
over-the-counter market.  Valuation discounts of 5 percent to 50 percent
are applied to publicly traded securities subject to resale restrictions
resulting from Rule 144 or contractual lock-ups, such as those commonly
associated with underwriting agreements or knowledge of material non-public
information.

The fair value of all other investments is determined in good faith by the
Managing General Partners under the direction of the Management Committee
after consideration of available relevant information.  There is no ready
market for the Partnership's investments in private companies or
unregistered securities of public companies.  Fair value is generally
defined as the amount the Partnership could reasonably expect to receive
for an investment in an orderly disposition based on a current sale.
Significant factors considered in the estimation of fair value include the
inherent illiquidity of and lack of marketability associated with venture
capital investments in private companies or unregistered securities, the
investee company's enterprise value established in the last round of
venture financing, changes in market conditions since the last round of
venture financing or since the last reporting period, the value of a
minority interest in the investee company, contractual restrictions on
resale typical of venture financing instruments, the investee company's
financial position and ability to obtain any necessary additional
financing, the investee company's performance as compared to its business
plan, and the investee company's progress towards initial public offering.
The values determined for the Partnership's investments in these securities
are based upon available information at the time the good faith valuations
are made and do not necessarily represent the amount which might ultimately
be realized, which could be higher or lower than the reported fair value.
It is possible that these estimates of value and the estimated amount of
time required to liquidate the assets will change as the Managing General
Partners gain additional information from their efforts to sell the
remaining investments and from information provided by the third party
retained to assist in selling the assets.

At December 31, 2005 and 2004, the investment portfolio included private
company investments and venture capital limited partnership investments
totaling $1,044,399 and $2,131,156, respectively, whose fair values were
established in good faith by the Managing General Partners under the
direction of the Management Committee in the absence of readily
ascertainable market values.  Because of the inherent uncertainty in the
valuation, the values may differ significantly from the values that would
have been used had a ready market for the securities existed, and the
differences could be material.

Venture capital limited partnership investments are valued based on the
fair value of the underlying investments.  Based on recent market analysis
and attempts to liquidate the Partnerships interests in its venture capital
limited partnership investments, management has valued all remaining
interests at $0.  Limited partnership distributions that are a return of
capital reduce the cost basis of the Partnership's investment.
Distributions from limited partnership cumulative earnings are reflected as
realized gains by the Partnership.

In the case of an other-than-temporary decline in fair value below cost
basis, an appropriate reduction in the cost basis is recognized as a
realized loss with the new cost basis being adjusted to equal the fair
value of the investment. Cost basis adjustments are reflected as "Realized
loss from investment write-offs" or "Net realized loss from venture capital
limited partnership investments" on the Statements of Operations.

Sales of equity investments are recorded on the trade date.  The basis on
which cost is determined in computing realized gains or losses is specific
identification.

Cash and Cash Equivalents
-------------------------

Cash and cash equivalents are principally comprised of cash invested in
demand accounts and money market instruments and are stated at cost plus
accrued interest.  The Partnership considers all money market and short-
term investments with an original maturity of three months or less to be
cash equivalents.

Net Decrease in Partners' Capital Resulting from Operations Per Unit
--------------------------------------------------------------------

Net decrease in partners' capital resulting from operations per Unit is
calculated by dividing the weighted average number of Units outstanding of
400,000 for the years ended December 31, 2005, 2004 and 2003, into the
total net decrease in partners' capital resulting from operations allocated
to the Limited Partners.  The Managing General Partners contributed 0.1
percent of total Limited Partner capital contributions and did not receive
any Partnership Units.

Provision for Income Taxes
--------------------------

No provision for income taxes has been made by the Partnership as the
Partnership is not directly subject to taxation.  The partners are to
report their respective shares of Partnership income or loss on their
individual tax returns.

The accompanying financial statements are prepared using accounting
principles generally accepted in the United States which may not equate to
tax accounting.  The cost of investments on a tax basis at December 31,
2005 and 2004, was $3,364,839 and $2,810,768, respectively.  At December
31, 2005 and 2004, gross unrealized appreciation and depreciation on
investments based on cost for federal income tax purposes were as follows:


<TABLE>
<CAPTION>
                                      December 31,   December 31,
                                          2005           2004
                                      ------------   ------------
<S>                                      <C>              <C>
Unrealized appreciation               $       547    $   717,774
Unrealized depreciation                (2,320,987)    (1,397,384)
                                        ---------      ---------
Net unrealized depreciation           $(2,320,440)   $  (679,610)
                                        =========      =========
</TABLE>

Reclassifications
-----------------

Certain balances in prior periods have been reclassified in accordance with
current year balances for comparability.

2.  Basis of Accounting and Presentation of the Statements
    ------------------------------------------------------

As of December 31, 2005, the Partnership is in liquidation and will not
continue as a going concern.  The accompanying financial statements are
shown on the liquidation basis, and all amounts have been presented at
their estimated liquidation value, which management believes approximates
its historical basis of accounting and as a result, no specific adjustments
have been made to the amounts presented or to the labeling of the
statements to reflect liquidation accounting.

3.  Related Party Transactions
    --------------------------

Related party costs are included in costs and expenses shown on the
Statements of Operations.  Related party costs in 2005, 2004 and 2003 were
as follows:

<TABLE>
<CAPTION>
                                 For the Years Ended December 31,
                              -------------------------------------
                               2005            2004           2003
                              ------          ------         ------

<S>                        <C>               <C>            <C>
Management fees              $ 28,121      $   44,690       $ 32,924
Independent General
 Partners' compensation        52,000          70,625         40,000
Reimbursable operating
 expenses:
  Investment operations       248,570         392,279        169,067
  Administrative, investor
   services and
   professional fees        1,054,595       1,526,710      1,252,019
  Computer services            91,963         142,891        106,107

</TABLE>

Management fees are equal to one quarter of one percent of the fair value
of Partnership assets for each quarter.  Management fees compensate the
Managing General Partners solely for General Partner Overhead (as defined
in the Partnership Agreement) incurred in supervising the operation and
management of the Partnership and the Partnership's investments.
Management fees due to the Managing General Partners were $1,153 and $3,924
and were included in due to related parties at December 31, 2005 and 2004,
respectively.

As compensation for their services, the Independent General Partners each
receive $14,000 annually, plus $1,500 for attendance at each meeting of the
Management Committee and committees thereof.  The Independent General
Partners are reimbursed for all out-of-pocket expenses relating to
attendance of the meetings, committees or otherwise of the Management
Committee.  The Independent General Partners each own 20 Units.

The Partnership reimburses the Managing General Partners for operating
expenses incurred in connection with the business of the Partnership.
Reimbursable operating expenses include expenses (other than Organizational
and Offering expenses and General Partner Overhead) such as investment
operations, administrative and investor services, and computer services.
The Managing General Partners of this Partnership serve in a similar
capacity for other partnerships, and all reimbursed expenses are allocated
to the various partnerships based on a number of factors including the size
of each partnership, the number of active portfolio companies, and the
amount of time spent by various employees of the Managing General Partners
on the specific affairs of any one partnership.  There were $830,861 and
$259,835 of such reimbursable expenses due to related parties at December
31, 2005 and 2004, respectively.

Under the terms of a computer service agreement, Technology Administrative
Management, a division of TFL, charges the Partnership for its share of
computer support costs.  These amounts are included in computer services
expenses.

As of December 31, 2005 and 2004, the Partnership has a gross due from
related party receivable of $0 and $224,594, respectively, related to its
investment in Dakota Holdings, LLC and Dakota Arms, Inc.  During 2005, the
Partnership advanced additional funds of $1,080,974 to the company for
operations.  During 2005, the Partnership recorded an allowance for
doubtful accounts of $370,519 against the receivable.  At December 31,
2005, $1,286,250 of this receivable was converted into additional equity
investments in Dakota Holdings and the remaining $19,318 was converted into
a bridge loan with an interest rate of 4.79 percent.  As a result of the
conversion, the allowance for doubtful accounts as described above was
reclassified to unrealized depreciation in the accompanying statements.

Retention bonuses were offered to and accepted by key employees of the
Managing General Partners in late 2002. The expense for these bonuses,
which were approved by the Independent General Partners during the
September 2002 Management Committee meeting, was prepaid by the Partnership
in October and December 2002. At December 31, 2005, the amount of prepaid
operating expenses was $186,180, and is being amortized over the remaining
expected employment period.  During 2005, 2004 and 2003, the Partnership
recognized $40,047, $40,044 and $40,044 as operating expense related to the
amortization of retention bonuses.  The bonuses, incremented by annual
salary increases, will be paid to those individuals who are still full-time
employees of the Managing General Partners in April 2007.  Upon the
resignation of personnel no adjustment to the retention bonus amount
previously paid by the Partnership to the Managing General Partners shall
occur until a replacement person is hired.

Officers of the Managing General Partners occasionally receive stock
options as compensation for serving on the Boards of Directors of portfolio
companies.  It is the Managing General Partners' policy that all such
compensation be transferred to the investing partnerships.  If the options
are non-transferable, they are not recorded as an asset of the Partnership.
Any profit from the exercise of such options will be transferred if and
when the options are exercised and the underlying stock is sold by the
officers.  Any such profit is allocated amongst the Partnership and
affiliated partnerships based upon their proportionate investments in the
portfolio company.  One of the Managing General Partners serves as interim
CEO and Chairman of the Board for Dakota Arms, Inc., a portfolio company.
The Managing General Partner does not receive any compensation for these
services.

4.  Allocation of Profits and Losses
    --------------------------------

In accordance with the Partnership Agreement (see Note 1), net profits and
losses of the Partnership are allocated based on the beginning-of-the-year
partners' capital balances as follows:

   (a)   Profits:

    (i)   First, to those partners with deficit capital
          account balances until such deficits have been
          eliminated; then

    (ii)  Second, to the partners as necessary to offset the
          net decrease in partners' capital resulting from
          operations and sales commissions previously allocated
          under (b)(ii) below; then

    (iii) 75 percent to the Limited Partners as a group in proportion
          to the number of Units held, 5 percent to the Limited Partners
          in proportion to the Unit Months of each Limited Partner,
          and 20 percent to the Managing General Partners.  Unit months
          are the number of half months a Unit would be outstanding
          if held from the date the original holder of such Unit
          was deemed admitted into the Partnership until the
          termination of the offering of Units.

   (b)   Losses:

    (i)   First, to the partners as necessary to offset the
          net profit previously allocated to the partners under
          (a) (iii) above; then

    (ii)  99 percent to the Limited Partners and 1 percent to the Managing
          General Partners.

Losses allocable to Limited Partners in excess of their capital account
balances will be allocated to the Managing General Partners, with net
profit thereafter otherwise allocable to those Limited Partners being
allocated to the Managing General Partners to the extent of such losses.

Losses from unaffiliated venture capital limited partnership investments
are allocated pursuant to section (b) above.  Gains are allocated 99
percent to the Limited Partners and 1 percent to the Managing General
Partners.

In no event are the Managing General Partners allocated less than 1 percent
of the net realized profit or loss of the Partnership.

5.  Equity Investments
    ------------------

All investments are valued at fair value as determined in good faith by the
Managing General Partners.

Restricted Securities
---------------------

At December 31, 2005 and 2004, restricted securities had aggregate costs of
$3,615,689 and $2,165,201 and aggregate fair values of $1,044,399 and
$2,131,156, respectively, representing 436.6 percent and 52.6 percent,
respectively, of total partners' capital of the Partnership.

Significant purchases, sales and write-offs of equity investments during
2005 are as follows:

Corautus Genetics Inc.
----------------------

In March 2005, the Partnership exercised a common stock warrant and
received 14,550 shares.  Subsequently, all the shares were sold for
proceeds of $58,348, resulting in a realized gain of $58,348.

Dakota Holdings, LLC
--------------------

In December 2005, the Partnership converted its due from portfolio company
of $1,305,568 to $1,286,250 of LLC units and the remaining $19,318 into a
bridge loan with an interest rate of 4.79 percent.

Icagen, Inc.
------------

In September 2005, the Partnership received a stock distribution in the
company from Medical Science Partners, a venture capital limited
partnership previously written off.  Subsequently, the Partnership sold its
holdings in the company for proceeds of $47,312 and recorded a realized
gain of $47,312.

Laser Diagnostic Technologies, Inc.
-----------------------------------

In April 2005, the Partnership sold its entire position in the company for
proceeds of $127,987, resulting in a realized gain of $17,907.

Onset Enterprises Associates, L.P.
----------------------------------

In September 2005, the Partnership received a cash distribution of $18,996
from Onset Enterprises Associates, L.P., a venture capital limited
partnership.  A gain of $3,836 was recorded.

Phase Forward Inc.
------------------

In March 2005, the Partnership received a stock distribution in the company
from Onset Enterprises Associates, L.P., a venture capital limited
partnership.  Subsequently, the Partnership sold its holdings in the
company for proceeds of $13,625 and recorded a realized gain of $13,625.

RedCell, Inc.
-------------

In September 2005, the Partnership recovered and recorded a gain of $86,037
from RedCell, an investment that was previously written off.

Sanarus Medical, Inc.
---------------------

In January 2005, the Partnership purchased 375,939 Series D Preferred
shares at a cost of $300,000.

Other Equity Investments
------------------------

Other significant changes reflected above relate to market value
fluctuations for publicly traded portfolio companies or changes in the fair
value of private companies as determined in accordance with the policy
described in Note 1 to the financial statements.

6.  Net Decrease (Increase) in Unrealized Depreciation of Equity
    ------------------------------------------------------------
    Investments
    -----------

In accordance with the accounting policy as stated in Note 1, the
Statements of Operations include a line item entitled "Net decrease
(increase) in unrealized depreciation of equity investments."  The table
below discloses details of the changes:

<TABLE>
<CAPTION>
                                         For the Years Ended December 31,
                                        ----------------------------------
                                         2005          2004          2003
                                        ------        ------        ------
<S>                                <C>           <C>            <C>
Unrealized appreciation
 from cost of marketable
  equity securities                 $       --   $       --   $   282,361

Unrealized (depreciation)
 appreciation from cost of
  non-marketable equity securities  (2,571,290)      34,045    (1,870,457)
                                     ---------     ---------     ---------
Unrealized (depreciation)
 appreciation from cost at
  end of year                       (2,571,290)      34,045    (1,588,096)

Unrealized appreciation
 (depreciation) from cost at
   beginning of year                    34,045   (1,588,096)   (3,791,850)

Reclass of allowance for doubtful
 accounts                              370,519           --            --
                                    ----------   ----------     ---------
Net (increase) decrease in
 unrealized depreciation of
 equity investments               $(2,166,726)   $1,554,051   $ 2,203,754
                                    =========     =========     =========
</TABLE>

7.  Cash and Cash Equivalents
    -------------------------

Cash and cash equivalents at December 31, 2005 and 2004, consisted of:

<TABLE>
<CAPTION>
                                           2005             2004
                                          ------           ------
<S>                                      <C>             <C>

Demand accounts                         $    2,795      $1,881,324
Money market accounts                           --              --
                                         ---------        --------
  Total                                 $    2,795      $1,881,324
                                         =========        ========
</TABLE>

8.  Borrowings
    ----------

In January 2002, the Partnership borrowed $1,147,180 from a financial
institution and pledged as collateral, the Partnership's shares in
Endocare, Inc. and GenStar Therapeutic Corporation (now Corautus Genetics
Inc. after a merger with another company in February 2003).  On January
2002, the value of Endocare, Inc. dropped below 10 percent of the face of
the note, resulting in the note being in default.  As a result, the
financial institution that issued the note took ownership of the Endocare,
Inc. shares, satisfying $562,968 of the term borrowings.  The remaining
note had an outstanding balance of $621,063, and bore interest at the
London Interbank Offered Rate plus 1.5 percent, which is payable quarterly.
The outstanding principal and any remaining accrued interest were due
December 30, 2004.  The note was a non-recourse note and was fully
collateralized by the Partnership's common share holdings in Corautus.  On
December 30, 2004, the Partnership turned over the Corautus shares to the
financial institution to satisfy the remaining balance on the note, and
recognized a gain from extinguishment of debt of $306,267, resulting from
the difference in fair value of the shares verses the amount of debt
outstanding.

9.  Distributions
    -------------

There were no distributions in 2005 or 2004.

10. Commitments and Contingencies
    -----------------------------

From time to time the Partnership becomes a party to financial instruments
with off-balance-sheet risk in the normal course of its business.
Generally, these instruments are commitments for future equity investment
fundings, equipment financing commitments, or accounts receivable lines of
credit that are outstanding but not currently fully utilized.  As they do
not represent current outstanding balances, these unfunded commitments are
properly not recognized in the financial statements.  At December 31, 2005
and 2004, there was $0 and $500,000 in unfunded commitments, respectively.

From time to time, the Partnership is subject to routine litigation
incidental to the business of the Partnership.  Although there can be no
assurances as to the ultimate disposition of these matters, it is the
opinion of the Managing General Partners, based upon the information
available at this time, that the expected outcome of these matters,
individually or in the aggregate, will not have a material adverse effect
on the results of operations and financial condition of the Partnership.

11. Financial Highlights
    --------------------
<TABLE>
<CAPTION>
                                    For The Years Ended December 31,
                                  -----------------------------------
                                   2005           2004          2003
                                  ------         ------        ------
<S>                               <C>            <C>          <C>
(all amounts on a per Unit basis)
Net asset value,
 beginning of period              $13.42        $13.53         $13.38

(Loss) gain from investment
 operations:
  Net investment loss              (3.69)           --            --
  Net realized and unrealized
   (loss) gain income on
   investments                     (3.98)         (.11)          .15
                                    ----          ----         -----
Total from investment
   operations                      (7.67)         (.11)          .15
                                    ----          ----         -----
Net asset value, end of period    $ 5.75        $13.42        $13.53
                                   =====          ====         =====


Total return                      (57.15)%        (.81)%        1.12%

Ratios to average net assets:
 Net investment loss              (38.48)%        0.00%         0.00%

 Expenses                         (48.14)%      (40.72)%      (30.02)%
</TABLE>

Pursuant to the Partnership Agreement, net profit shall be allocated first
to those Partners with deficit capital account balances until such deficits
have been eliminated. The net asset values shown above assume the
Partnership is in liquidation.  Per the terms of the limited partnership
agreement, subsequent to final liquidation of all partnership assets, the
General Partners would be required to contribute capital equal to the
amount of the General Partners' deficit capital account, if applicable.


<PAGE>


                              SIGNATURES
                              ----------

Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Report to be signed on its behalf by the
undersigned, thereunto duly authorized.

                         TECHNOLOGY FUNDING VENTURE PARTNERS IV,
                         AN AGGRESSIVE GROWTH FUND, L.P.

                         By:  TECHNOLOGY FUNDING INC.
                              TECHNOLOGY FUNDING LTD.
                              Managing General Partners

Date:  March --, 2006    By:  /s/Charles R. Kokesh
                               --------------------------------
                                 Charles R. Kokesh
                                 President, Chief Executive Officer,
                                 Chief Financial Officer and
                                 Chairman of Technology Funding Inc.
                                 and Managing General Partner of
                                 Technology Funding Ltd.

Pursuant to the requirements of the Securities Exchange Act of 1934, this
Report on Form 10-K has been signed by the following persons on behalf of
the Registrant and in the capacities and on the dates indicated:

          Signature           Capacity                 Date
          ---------           --------                 ----

 /s/Charles R. Kokesh         President, Chief         March --, 2006
------------------------      Executive Officer,
    Charles R. Kokesh         Chief Financial Officer,
                              and Chairman of
                              Technology Funding Inc.
                              and Managing General
                              Partner of Technology
                              Funding Ltd.

The above represents a majority of the Board of Directors of Technology
Funding Inc. and the General Partners of Technology Funding Ltd.

Technology Funding Partners IV, L.P.     11:03 AM     03/28/06
(a Delaware limited partnership in process of liquidation)

Page 24 of 43
Technology Funding Partners IV, L.P.
(a Delaware limited partnership in process of liquidation )

Technology Funding Partners IV, L.P.
(a Delaware limited partnership in process of liquidation)

Technology Funding Partners IV, L.P.
(a Delaware limited partnership in process of liquidation)